How Will the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Grow Over the Forecast Period Based on Its Expected CAGR?
The market size for percutaneous transluminal coronary angioplasty (PTCA) dilation catheters has seen a significant increase in recent years. The market is projected to surge from $1.83 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. Factors that contributed to the growth during the historic period include a rise in cardiovascular diseases, an aging populace, a heightened inclination towards minimally invasive procedures, escalating obesity rates, and enhanced healthcare infrastructure.
The market for percutaneous transluminal coronary angioplasty (PTCA) dilation catheters is projected to experience significant expansion in the upcoming years, reaching a value of $2.52 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. The reasons for this growth during the projected period include a greater focus on proactive health care, patients choosing for lesser hospital stays, beneficial insurance coverage policies, the rising use of drug-eluting balloons, and advancements in diagnostic methods. Key market trends for the forecast period encompass technological advancements, market development in emerging regions, enhanced patient consciousness, custom-made catheters, and the adoption of imaging technologies.
Which Macro and Microeconomic Factors Are Accelerating the Growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?
The surge in cardiovascular illnesses is predicted to fuel the expansion of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market. There’s been a noted rise in these diseases due to lifestyle habits such as unhealthy eating, insufficient physical activity, heightened stress levels, and an aging global population. PTCA dilation catheters, which are used to widen or unblock coronary arteries for improved heart blood supply, are central in the treatment of these conditions. For example, the American Heart Association, a United States public health group dedicated to cardiovascular research, estimated that come 2050, there will be 45 million US adults battling some form of cardiovascular disease, a substantial rise from the 28 million in 2020. Included in this forecast is a notable uptick in hypertension, expected to escalate from 51.2% to 61.0%, and obesity, predicted to soar from 43.1% to 60.6%. Consequently, the rise in cardiovascular conditions is a strong driving force for the growth of the PTCA dilation catheters market.
Request Your Free Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19641&type=smp
Who Are the Dominant Players Expanding Their Reach in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?
Major companies operating in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group
What Are the Top Trends Shaping the Evolution of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?
Leading firms in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are putting their efforts into creating innovatively advanced products. These include dilation catheters integrated with twin-wall technology, which significantly improves the strength of the balloon and successful dilation of arteries. A medical device that incorporates twin-wall technology is designed for accurate and controlled dilation procedures. The unique design includes two concentric layers, which contribute to increased strength, flexibility, and durability of the catheter. For example, SIS Medical AG, a Swiss medical device corporation, introduced the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter integrated with Twin-Wall technology in the United States in February 2023. This catheter can resist extremely high pressure with a rated burst pressure capacity of 35 atm and shows low compliance, making it suitable for post-dilatation of under-expanded stents. The unique architecture grants excellent pressure resistance and minimal compliance, thus allowing effective treatment of challenging coronary lesions without the risk of over-dilation.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Core Categories and Segments in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Driving Demand and Growth?
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market covered in this report is segmented –
1) By Type: Semi-Compliant Type, Non-Compliant Type
2) By Material Type: Polyurethane, Nylon, Other Material Types
3) By Application: Hospitals, Medical Research Institute, Other Applications
Subsegments:
1) By Semi-Compliant Type: Standard Semi-Compliant Catheters, Specialized Semi-Compliant Catheters
2) By Non-Compliant Type: Standard Non-Compliant Catheters, High-Pressure Non-Compliant Catheters
Which Regions Are Setting the Pace for Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Growth?
North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2024. The regions covered in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Defines the Scope of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?
Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical devices used to open narrowed or blocked coronary arteries. They involve inserting a catheter with a small balloon at its tip into the artery, then inflating the balloon to widen the artery and improve blood flow. This minimally invasive procedure helps restore proper circulation to the heart.
Browse Through More Similar Reports By The Business Research Company:
Intravascular Catheters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report
Transcatheter Aortic Valve Replacement Global Market Report 2024
Transcatheter Valve Repair System Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
